Rapisarda S, Silcox J, Case P, Palacios W, Stopka T, Zaragoza S
AIDS Behav. 2024; 29(2):584-588.
PMID: 39676088
PMC: 11813815.
DOI: 10.1007/s10461-024-04567-w.
Rapisarda S, Silcox J, Case P, Palacios W, Stopka T, Zaragoza S
AIDS Behav. 2024; 29(2):562-583.
PMID: 39511061
PMC: 11813996.
DOI: 10.1007/s10461-024-04540-7.
Akiba C, Smith J, Wenger L, Morris T, Patel S, Bluthenthal R
SSM Qual Res Health. 2024; 5.
PMID: 38957482
PMC: 11218888.
DOI: 10.1016/j.ssmqr.2024.100421.
Walker S, Curtis M, Kirwan A, Thatcher R, Dietze P
Harm Reduct J. 2024; 21(1):51.
PMID: 38402389
PMC: 10894474.
DOI: 10.1186/s12954-024-00960-9.
Brooks H, Speed K, Dong K, Salvalaggio G, Pauly B, Taylor M
PLoS One. 2024; 19(2):e0297584.
PMID: 38359010
PMC: 10868849.
DOI: 10.1371/journal.pone.0297584.
Early disruptions to syringe services programs during the Russian invasion of Ukraine.
Nikitin B, Bromberg D, Pykalo I, Ivasiy R, Islam Z, Altice F
Front Public Health. 2023; 11:1229057.
PMID: 38074770
PMC: 10702598.
DOI: 10.3389/fpubh.2023.1229057.
Harm reduction stories: leveraging graphic medicine to engage veterans in substance use services within the VA.
Harvey L, Branch-Elliman W, Boudreau J, Sliwinski S, Gifford A, Ho M
Harm Reduct J. 2023; 20(1):177.
PMID: 38057789
PMC: 10702088.
DOI: 10.1186/s12954-023-00886-8.
Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature.
Jakubowski A, Fowler S, Fox A
Addict Sci Clin Pract. 2023; 18(1):40.
PMID: 37301953
PMC: 10256972.
DOI: 10.1186/s13722-023-00394-x.
The integration of harm reduction services in the Veterans Health Administration (VHA): a qualitative analysis of barriers and facilitators.
Harvey L, Sliwinski S, Flike K, Boudreau J, Gifford A, Branch-Elliman W
J Addict Dis. 2023; 42(4):326-334.
PMID: 37154222
PMC: 10630529.
DOI: 10.1080/10550887.2023.2210021.
Risk factors of HIV and variation in access to clean needles among people who inject drugs in Pakistan.
Capelastegui F, Trickey A, Thompson L, Reza T, Emmanuel F, Cholette F
Pathog Glob Health. 2023; 117(8):696-707.
PMID: 36950726
PMC: 10614703.
DOI: 10.1080/20477724.2023.2191234.
How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study.
Lambdin B, Wenger L, Bluthenthal R, Bartholomew T, Tookes H, LaKosky P
Harm Reduct J. 2023; 20(1):26.
PMID: 36855181
PMC: 9972698.
DOI: 10.1186/s12954-023-00755-4.
Client Characteristics Associated with Desire for Additional Services at Syringe Exchange Programs.
Franz D, Cioffi C
J Subst Use. 2023; 27(6):604-610.
PMID: 36644655
PMC: 9838586.
DOI: 10.1080/14659891.2021.1967486.
Medications for Opioid Use Disorder Do Help Patients.
Nguyen K, Forbriger J, Forbriger A, Schwarz E
Mo Med. 2022; 119(3):271-276.
PMID: 36035557
PMC: 9324703.
Harm minimisation for self-harm: a cross-sectional survey of British clinicians' perspectives and practices.
Haris A, Pitman A, Mughal F, Bakanaite E, Morant N, Rowe S
BMJ Open. 2022; 12(6):e056199.
PMID: 35980724
PMC: 9171231.
DOI: 10.1136/bmjopen-2021-056199.
Addressing injecting related risks among people who inject both opioids and stimulants: Findings from an Australian survey of people who inject drugs.
Brener L, Caruana T, Broady T, Cama E, Ezard N, Madden A
Addict Behav Rep. 2022; 15:100398.
PMID: 35005190
PMC: 8717740.
DOI: 10.1016/j.abrep.2021.100398.
Syringe Services Programs' Role in Ending the HIV Epidemic in the U.S.: Why We Cannot Do It Without Them.
Broz D, Carnes N, Chapin-Bardales J, Des Jarlais D, Handanagic S, Jones C
Am J Prev Med. 2021; 61(5 Suppl 1):S118-S129.
PMID: 34686281
PMC: 11334402.
DOI: 10.1016/j.amepre.2021.05.044.
Wounds and Skin and Soft Tissue Infections in People Who Inject Drugs and the Utility of Syringe Service Programs in Their Management.
Sanchez D, Tookes H, Pastar I, Lev-Tov H
Adv Wound Care (New Rochelle). 2021; 10(10):571-582.
PMID: 33913781
PMC: 8312019.
DOI: 10.1089/wound.2020.1243.
Shifting the paradigm: physician-authorized, student-led efforts to provide harm reduction services amidst legislative opposition.
McMullen T, Naeim M, Newark C, Oliphant H, Suchard J, Banimahd F
Subst Abuse Treat Prev Policy. 2021; 16(1):27.
PMID: 33761954
PMC: 7992799.
DOI: 10.1186/s13011-021-00362-1.
Lessons learned from the Amsterdam Cohort Studies among people who use drugs: a historical perspective.
Van Santen D, Coutinho R, van den Hoek A, van Brussel G, Buster M, Prins M
Harm Reduct J. 2021; 18(1):2.
PMID: 33407562
PMC: 7789277.
DOI: 10.1186/s12954-020-00444-6.
Southern African HIV Clinicians Society guidelines for harm reduction.
Scheibe A, Sibeko G, Shelly S, Rossouw T, Zishiri V, Venter W
South Afr J HIV Med. 2021; 21(1):1161.
PMID: 33391833
PMC: 7756663.
DOI: 10.4102/sajhivmed.v21i1.1161.